Improving RNA interference in mammalian cells by 4 '-thio-modified small interfering RNA (siRNA): effect on siRNA activity and nuclease stability when used in …

P Dande, TP Prakash, N Sioufi, H Gaus… - Journal of medicinal …, 2006 - ACS Publications
P Dande, TP Prakash, N Sioufi, H Gaus, R Jarres, A Berdeja, EE Swayze, RH Griffey, B Bhat
Journal of medicinal chemistry, 2006ACS Publications
A systematic structure− activity relationship study of 4 '-thioribose containing small interfering
RNAs (siRNAs) has led to the identification of highly potent and stable antisense constructs.
To enable this optimization effort for both in vitro and in vivo applications, we have
significantly improved the yields of 4 '-thioribonucleosides by using a chirally pure (R)-
sulfoxide precursor. siRNA duplexes containing strategically placed regions of 4 '-thio-RNA
were synthesized and evaluated for RNA interference activity and plasma stability. Stretches …
A systematic structure−activity relationship study of 4‘-thioribose containing small interfering RNAs (siRNAs) has led to the identification of highly potent and stable antisense constructs. To enable this optimization effort for both in vitro and in vivo applications, we have significantly improved the yields of 4‘-thioribonucleosides by using a chirally pure (R)-sulfoxide precursor. siRNA duplexes containing strategically placed regions of 4‘-thio-RNA were synthesized and evaluated for RNA interference activity and plasma stability. Stretches of 4‘-thio-RNA were well tolerated in both the antisense and sense strands. However, optimization of both the number and placement of 4‘-thioribonucleosides was necessary for maximal potency. These optimized siRNAs were generally equipotent or superior to native siRNAs and exhibited increased thermal and plasma stability. Furthermore, significant improvements in siRNA activity and plasma stability were achieved by judicious combination of 4‘-thioribose with 2‘-O-methyl and 2‘-O-methoxyethyl modifications. These optimized 4‘-thio-siRNAs may be valuable for developing stable siRNAs for therapeutic applications.
ACS Publications